Cargando…

Simplifying ART cohort monitoring: Can pharmacy stocks provide accurate estimates of patients retained on antiretroviral therapy in Malawi?

BACKGROUND: Routine monitoring of patients on antiretroviral therapy (ART) is crucial for measuring program success and accurate drug forecasting. However, compiling data from patient registers to measure retention in ART is labour-intensive. To address this challenge, we conducted a pilot study in...

Descripción completa

Detalles Bibliográficos
Autores principales: Tweya, Hannock, Feldacker, Caryl, Ben-Smith, Anne, Harries, Anthony D, Komatsu, Ryuichi, Jahn, Andreas, Phiri, Sam, Tassie, Jean-Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502524/
https://www.ncbi.nlm.nih.gov/pubmed/22818397
http://dx.doi.org/10.1186/1472-6963-12-210
_version_ 1782250359015604224
author Tweya, Hannock
Feldacker, Caryl
Ben-Smith, Anne
Harries, Anthony D
Komatsu, Ryuichi
Jahn, Andreas
Phiri, Sam
Tassie, Jean-Michel
author_facet Tweya, Hannock
Feldacker, Caryl
Ben-Smith, Anne
Harries, Anthony D
Komatsu, Ryuichi
Jahn, Andreas
Phiri, Sam
Tassie, Jean-Michel
author_sort Tweya, Hannock
collection PubMed
description BACKGROUND: Routine monitoring of patients on antiretroviral therapy (ART) is crucial for measuring program success and accurate drug forecasting. However, compiling data from patient registers to measure retention in ART is labour-intensive. To address this challenge, we conducted a pilot study in Malawi to assess whether patient ART retention could be determined using pharmacy records as compared to estimates of retention based on standardized paper- or electronic based cohort reports. METHODS: Twelve ART facilities were included in the study: six used paper-based registers and six used electronic data systems. One ART facility implemented an electronic data system in quarter three and was included as a paper-based system facility in quarter two only. Routine patient retention cohort reports, paper or electronic, were collected from facilities for both quarter two [April–June] and quarter three [July–September], 2010. Pharmacy stock data were also collected from the 12 ART facilities over the same period. Numbers of ART continuation bottles recorded on pharmacy stock cards at the beginning and end of each quarter were documented. These pharmacy data were used to calculate the total bottles dispensed to patients in each quarter with intent to estimate the number of patients retained on ART. Information for time required to determine ART retention was gathered through interviews with clinicians tasked with compiling the data. RESULTS: Among ART clinics with paper-based systems, three of six facilities in quarter two and four of five facilities in quarter three had similar numbers of patients retained on ART comparing cohort reports to pharmacy stock records. In ART clinics with electronic systems, five of six facilities in quarter two and five of seven facilities in quarter three had similar numbers of patients retained on ART when comparing retention numbers from electronically generated cohort reports to pharmacy stock records. Among paper-based facilities, an average of 13 4 hours was needed to calculate patient retention for cohort reporting using patient registers as compared to 2.25 hours using pharmacy stock cards. CONCLUSION: The numbers of patients retained on ART as estimated using pharmacy stock records were largely similar to estimates based on either paper registers or electronic data system. Furthermore, less time and staff effort was needed to estimate ART patient retention using pharmacy stock records versus paper-based registers. Reinforcing ARV stock management may improve the precision of estimates.
format Online
Article
Text
id pubmed-3502524
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35025242012-11-21 Simplifying ART cohort monitoring: Can pharmacy stocks provide accurate estimates of patients retained on antiretroviral therapy in Malawi? Tweya, Hannock Feldacker, Caryl Ben-Smith, Anne Harries, Anthony D Komatsu, Ryuichi Jahn, Andreas Phiri, Sam Tassie, Jean-Michel BMC Health Serv Res Research Article BACKGROUND: Routine monitoring of patients on antiretroviral therapy (ART) is crucial for measuring program success and accurate drug forecasting. However, compiling data from patient registers to measure retention in ART is labour-intensive. To address this challenge, we conducted a pilot study in Malawi to assess whether patient ART retention could be determined using pharmacy records as compared to estimates of retention based on standardized paper- or electronic based cohort reports. METHODS: Twelve ART facilities were included in the study: six used paper-based registers and six used electronic data systems. One ART facility implemented an electronic data system in quarter three and was included as a paper-based system facility in quarter two only. Routine patient retention cohort reports, paper or electronic, were collected from facilities for both quarter two [April–June] and quarter three [July–September], 2010. Pharmacy stock data were also collected from the 12 ART facilities over the same period. Numbers of ART continuation bottles recorded on pharmacy stock cards at the beginning and end of each quarter were documented. These pharmacy data were used to calculate the total bottles dispensed to patients in each quarter with intent to estimate the number of patients retained on ART. Information for time required to determine ART retention was gathered through interviews with clinicians tasked with compiling the data. RESULTS: Among ART clinics with paper-based systems, three of six facilities in quarter two and four of five facilities in quarter three had similar numbers of patients retained on ART comparing cohort reports to pharmacy stock records. In ART clinics with electronic systems, five of six facilities in quarter two and five of seven facilities in quarter three had similar numbers of patients retained on ART when comparing retention numbers from electronically generated cohort reports to pharmacy stock records. Among paper-based facilities, an average of 13 4 hours was needed to calculate patient retention for cohort reporting using patient registers as compared to 2.25 hours using pharmacy stock cards. CONCLUSION: The numbers of patients retained on ART as estimated using pharmacy stock records were largely similar to estimates based on either paper registers or electronic data system. Furthermore, less time and staff effort was needed to estimate ART patient retention using pharmacy stock records versus paper-based registers. Reinforcing ARV stock management may improve the precision of estimates. BioMed Central 2012-07-20 /pmc/articles/PMC3502524/ /pubmed/22818397 http://dx.doi.org/10.1186/1472-6963-12-210 Text en Copyright ©2012 Tweya et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Tweya, Hannock
Feldacker, Caryl
Ben-Smith, Anne
Harries, Anthony D
Komatsu, Ryuichi
Jahn, Andreas
Phiri, Sam
Tassie, Jean-Michel
Simplifying ART cohort monitoring: Can pharmacy stocks provide accurate estimates of patients retained on antiretroviral therapy in Malawi?
title Simplifying ART cohort monitoring: Can pharmacy stocks provide accurate estimates of patients retained on antiretroviral therapy in Malawi?
title_full Simplifying ART cohort monitoring: Can pharmacy stocks provide accurate estimates of patients retained on antiretroviral therapy in Malawi?
title_fullStr Simplifying ART cohort monitoring: Can pharmacy stocks provide accurate estimates of patients retained on antiretroviral therapy in Malawi?
title_full_unstemmed Simplifying ART cohort monitoring: Can pharmacy stocks provide accurate estimates of patients retained on antiretroviral therapy in Malawi?
title_short Simplifying ART cohort monitoring: Can pharmacy stocks provide accurate estimates of patients retained on antiretroviral therapy in Malawi?
title_sort simplifying art cohort monitoring: can pharmacy stocks provide accurate estimates of patients retained on antiretroviral therapy in malawi?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502524/
https://www.ncbi.nlm.nih.gov/pubmed/22818397
http://dx.doi.org/10.1186/1472-6963-12-210
work_keys_str_mv AT tweyahannock simplifyingartcohortmonitoringcanpharmacystocksprovideaccurateestimatesofpatientsretainedonantiretroviraltherapyinmalawi
AT feldackercaryl simplifyingartcohortmonitoringcanpharmacystocksprovideaccurateestimatesofpatientsretainedonantiretroviraltherapyinmalawi
AT bensmithanne simplifyingartcohortmonitoringcanpharmacystocksprovideaccurateestimatesofpatientsretainedonantiretroviraltherapyinmalawi
AT harriesanthonyd simplifyingartcohortmonitoringcanpharmacystocksprovideaccurateestimatesofpatientsretainedonantiretroviraltherapyinmalawi
AT komatsuryuichi simplifyingartcohortmonitoringcanpharmacystocksprovideaccurateestimatesofpatientsretainedonantiretroviraltherapyinmalawi
AT jahnandreas simplifyingartcohortmonitoringcanpharmacystocksprovideaccurateestimatesofpatientsretainedonantiretroviraltherapyinmalawi
AT phirisam simplifyingartcohortmonitoringcanpharmacystocksprovideaccurateestimatesofpatientsretainedonantiretroviraltherapyinmalawi
AT tassiejeanmichel simplifyingartcohortmonitoringcanpharmacystocksprovideaccurateestimatesofpatientsretainedonantiretroviraltherapyinmalawi